PhaseV news and updates

Every material change AI Health Index has tracked at PhaseV: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Follow this change log by RSS

Free for your reader, newsletter or automation tool. One feed covers the whole index, and every category has its own.

All feeds and terms
Impact
Type
1 entry
Showing changes for PhaseV only.Show the full log

November 2026

P
PhaseV
Nov 3, 2026
HighVerified
Product / capability

PhaseV launched BonV, an agentic layer that takes a plain language clinical development question, proposes an editable staged plan, runs PhaseV modules such as causal modeling, target trial emulation and trial optimization, and produces a recommendation, trial synopsis and decision memo. Projects get shared workspaces with reviewer, budget holder and final sign off roles, and BonV can run in a sponsor's private cloud or an isolated PhaseV hosted environment.

Our read

Sponsors get one workspace that chains PhaseV's separate optimizers with a human approval at each step and a recorded decision trail, plus a private cloud deployment option that matters for data control reviews. Rollout is phased, so buyers should confirm access and the onboarding work with Forward Deployed Engineers.

Related axis: Autonomy and Oversight ModelVendor announcementView source

What has changed at PhaseV recently?

The most recent change AI Health Index logged at PhaseV is dated Nov 3, 2026. PhaseV launched BonV, an agentic layer that takes a plain language clinical development question, proposes an editable staged plan, runs PhaseV modules such as causal modeling, target trial emulation and trial optimization, and produces a recommendation, trial synopsis and decision memo.